Author(s):
Praveenkumar A., Megaranjani S., Maheswari V., Loganayagi M.
Email(s):
loganayagimurugan1@gmail.com
DOI:
10.52711/0975-4385.2025.00040 
Address:
Praveenkumar A., Megaranjani S., Maheswari V., Loganayagi M.*
1Department of Pharmacognosy, The Erode College of Pharmacy, Erode, Tamil Nadu, India.
2Assistant Professor, Department of Pharmacognosy, The Erode College of Pharmacy, Erode, Tamil Nadu, India.
3The Tamil Nadu Dr. M.G.R. Medical University, Tamil Nadu, India.
*Corresponding Author
Published In:
Volume - 17,
Issue - 3,
Year - 2025
ABSTRACT:
Cannabis sativa is a fascinating plant that has caught the eye of many across various fields, including science, medicine, industry, and politics. This in-depth look dives into its unique botanical traits, chemical makeup, healing properties, industrial uses, and the rules that govern it. Originally from Central Asia, Cannabis sativa is now grown all over the globe and is celebrated for its rich variety of phytochemicals, especially in industrial markets. Thanks to advancements in biotechnology and genetics, we're seeing better strain development, higher yields, and more targeted medical applications. However, challenges remain, such as inconsistent regulations, quality control problems, and the pressing need for more clinical trials to establish its safety and effectiveness. As interest in this plant continues to rise, it's essential to adopt a well-rounded approach that considers scientific research, public health, and socioeconomic factors. This study highlights the importance of collaborative research and thoughtful policymaking to harness the benefits of Cannabis sativa while steering clear of potential risks.
Cite this article:
Praveenkumar A., Megaranjani S., Maheswari V., Loganayagi M.. Cannabis sativa: A Comprehensive Exploration of a Multifaceted Plant. Research Journal of Pharmacognosy and Phytochemistry. 2025; 17(3):247-0. doi: 10.52711/0975-4385.2025.00040
Cite(Electronic):
Praveenkumar A., Megaranjani S., Maheswari V., Loganayagi M.. Cannabis sativa: A Comprehensive Exploration of a Multifaceted Plant. Research Journal of Pharmacognosy and Phytochemistry. 2025; 17(3):247-0. doi: 10.52711/0975-4385.2025.00040 Available on: https://rjpponline.org/AbstractView.aspx?PID=2025-17-3-10
REFERENCES:
1. Clarke RC, Merlin MD. Cannabis: Evolution and Ethnobotany. Berkeley: University of California Press; 2013.
2. American Civil Liberties Union. A Tale of Two Countries: Racially Targeted Arrests in the Era of Marijuana Reform. New York: ACLU; 2020.
3. Russo EB. History of cannabis and its preparations in saga, science, and sobriquet. Chem Biodivers. 2007; 4(8): 1614–48.
4. Small E. Evolution and classification of Cannabis sativa (marijuana, hemp) in relation to human utilization. Bot Rev. 2015; 81(3): 189–294.
5. Kanittha Nakkliang, Onuma Zongram, Chitlada Areesantichai, Kanchana Rungsihirunrat. Assessment of Genetic relationship among Cannabis sativa L. in Thailand based on ISSR and their Phytoconstituents properties. Research Journal of Pharmacy and Technology, 2023; 16(5): 2197-4.
6. Thiruchelvi. R, K. Kavitha, K. Shankari. New Biotechnological Routes for Greener Bio-plastics from Seaweeds. Research J. Pharm. and Tech. 2020; 13(5): 2488-2492.
7. Schultes RE, Hofmann A. The Botany and Chemistry of Hallucinogens. Springfield: Charles C. Thomas; 1980.
8. Namrta Choudhary, M.B. Siddiqui, Shazia, K.M. Abdul Raoof. Phytochemical aspect of Cannabis sativa (L.). Research J. Science and Tech. 2013; 5(2): 284-288.
9. Hillig KW, Mahlberg PG. A chemotaxonomic analysis of terpenoid variation in Cannabis. Biochem Syst Ecol. 2004; 32(10): 875–91.
10. Izzo AA, Borrelli F, Capasso R, et al. non-psychotropic plant cannabinoids: New therapeutic opportunities from an ancient herb. Trends Pharmacol Sci. 2009; 30(10): 515–27.
11. Chandra S, Lata H, Khan IA, et al. Cannabis cultivation: Methodological issues for obtaining medical-grade product. Epilepsy Behav. 2017; 70(Pt B): 302–12.
12. Ranieri R, Marasco D, Bifulco M, et al. Cannabis and cannabinoids: From traditional medicine to modern therapeutic applications. Curr Med Chem. 2020; 27(22): 3637–55.
13. ElSohly MA, Slade D. Chemical constituents of marijuana: The complex mixture of natural cannabinoids. Life Sci. 2005; 78(5): 539–48.
14. Pertwee RG. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-THC, CBD and Δ9-THCV. Br J Pharmacol. 2008; 153(2): 199–215.
15. Blessing EM, Steenkamp MM, Manzanares J, et al. Cannabidiol as a potential treatment for anxiety disorders. Neurotherapeutics. 2015; 12(4): 825–36.
16. Mechoulam R, Parker LA. The endocannabinoid system and the brain. Annu Rev Psychol. 2013; 64: 21–47.
17. Russo EB. Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011; 163(7): 1344–64.
18. Stott CG, Guy GW. Cannabinoids for the pharmaceutical industry. Euphytica. 2004; 140(1–2): 83–93.
19. Komal Sharma, Rinu Rana, M S Ashawat. Preliminary Phytochemical Screening of Leaves, Stems and Roots of wild Cannabis sativa. Research Journal of Pharmacognosy and Phytochemistry. 2022; 14(1): 19-2.
20. Devinsky O, Cross JH, Laux L, et al. Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. N Engl J Med. 2017; 376(21): 2011–20.
21. Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for medical use: A systematic review and meta-analysis. JAMA. 2015; 313(24): 2456–73.
22. Cherniakov I, Shlosberg D, Domb AJ, et al. New developments in the delivery of cannabinoids. Drug Deliv Transl Res. 2017; 7(6): 735–47.
23. Swagata Dilip Tavhare, Rabinarayan Acharya, Bhagyashri Vaghora, Vinay Shukla. Comparative evaluation of physicochemical, qualitative and chromatographic profile of unprocessed and processed Cannabis sativa L (Bhanga) leaves. Research Journal of Pharmacy and Technology. 2023; 16(11): 5341-6.
24. Li HL. An archaeological and historical account of cannabis in China. Econ Bot. 1974; 28(4): 437–48.
25. Zuardi AW. History of cannabis as a medicine: A review. Braz J Psychiatry. 2006; 28(2): 153–7.
26. Aarti, Yumnam Devashree. The Phytotoxic Effect of Aqueous extract of Cannabis Sativa on the Germination and Growth of Cicerarietinum. Research J. Pharm. and Tech., 2018; 11(11): 5096-5100.
27. Russo EB. Cannabinoids in the management of difficult to treat pain. Ther Clin Risk Manag. 2008; 4(1): 245–59.
28. Lee MA. Smoke Signals: A Social History of Marijuana. New York: Scribner; 2012.
29. Hall W, Lynskey M. Evaluating the public health impacts of legalizing recreational cannabis use in the United States. Addiction. 2016; 111(10): 1764–73.
30. Bridgeman MB, Abazia DT. Medicinal cannabis: History, pharmacology, and implications for the acute care setting. Pharm Ther. 2017; 42(3): 180–8.
31. Sarris J, Sinclair J, Karamacoska D, et al. Medicinal cannabis for psychiatric disorders: A clinically-focused systematic review. BMC Psychiatry. 2020; 20(1): 24.
32. Ben Amar M. Cannabinoids in medicine: A review of their therapeutic potential. J Ethnopharmacol. 2006; 105(1–2): 1–25.
33. Callaway JC. Hempseed as a nutritional resource: An overview. Euphytica. 2004; 140(1): 65–72.
34. Fortune Business Insights. Hemp Market Size, Share & COVID-19 Impact Analysis, 2020–2027. 2020.
35. Crippa JA, Zuardi AW, Martín-Santos R, et al. Cannabis and anxiety: A critical review of the evidence. Hum Psychopharmacol. 2009; 24(7): 515–23.
36. National Institute on Drug Abuse. Marijuana Research Report. Bethesda: NIDA; 2020.
37. European Monitoring Centre for Drugs and Drug Addiction. European Drug Report 2021: Trends and Developments. Luxembourg: Publications Office of the European Union; 2021.
38. Lynch ME, Ware MA. Cannabinoids for the treatment of chronic non-cancer pain: An updated systematic review of randomized controlled trials. J Neuroimmune Pharmacol. 2015; 10(2): 293–301.
39. Bachhuber MA, Saloner B, Cunningham CO, et al. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999–2010. JAMA Intern Med. 2014; 174(10): 1668–73.
40. Boehnke KF, Litinas E, Clauw DJ. Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain. J Pain. 2016; 17(6): 739–44.
41. Hangane Ronald, Ketan Patil, Astha Pandey. Detection of Cannabis sativa by various Analytical Techniques. Research Journal of Pharmacy and Technology 2023; 16(6): 2917-0.
42. Abrams DI. The therapeutic effects of cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report. Eur J Intern Med. 2018; 49: 7–11.
43. Volkow ND, Baler RD, Compton WM, et al. Adverse health effects of marijuana use. N Engl J Med. 2014; 370(23): 2219–27.
44. MacCallum CA, Russo EB. Practical considerations in medical cannabis administration and dosing. Eur J Intern Med. 2018; 49: 12–9.